Overview
- Editors:
-
-
Oscar R. Colegio
-
Department of Dermatology, Yale School of Medicine, New Haven, USA
Assists in identifying the immunosuppressant responsible for a specific adverse effect in transplant patients
Provides guidance in distinguishing the cutaneous adverse effects of antiviral agents from effects directly due to HIV disease
Identifies cutaneous manifestations of primary immunodeficiencies
Proposes appropriate treatment strategies?
Access this book
Other ways to access
Table of contents (10 chapters)
-
-
- Raj Chovatiya, Oscar R. Colegio
Pages 1-34
-
- Samantha F. Vincent, Megan Casady, Anna Chacon, Anthony A. Gaspari
Pages 35-51
-
- Barry Ladizinski, Marigdalia Ramirez-Fort, Megan Shelton, Aisha Sethi
Pages 53-71
-
- Lucinda Kohn, Oscar R. Colegio
Pages 73-90
-
- Amit Mittal, Günther F. L. Hofbauer, Oscar R. Colegio
Pages 91-116
-
- Johanna Sheu, Vinod E. Nambudiri, Allison L. Goddard, Jennifer T. Huang, Arturo P. Saavedra
Pages 117-137
-
- Stanislav N. Tolkachjov, Jerry D. Brewer
Pages 139-153
-
- Sharon Rose, Shivani B. Kaushik, Mark Lebwohl
Pages 155-165
-
- Ravinder S. Gogia, Shawnbir Gogia, Sarah T. Arron
Pages 167-183
-
- Joyce Y. Cheng, Oscar R. Colegio
Pages 185-202
-
Back Matter
Pages 203-211
About this book
In this book, expert dermatologists review state of the art knowledge concerning the clinical presentation and management of cutaneous diseases that develop in immunosuppressed individuals. A major aim is to enable dermatologists to identify the specific immunosuppressant responsible for a specific adverse effect in patients receiving a complex medication regimen in the setting of transplantation. Further, the book will help the dermatologist to distinguish the cutaneous adverse effects of antiviral agents from effects arising directly from advancing HIV disease. Recognition of the cutaneous manifestations of often less common primary immunodeficiencies will also be emphasized. A final goal is to improve patient outcomes by identifying treatment strategies for skin disease arising in the immunosuppressed state. This book will be invaluable for a broad audience, from practicing dermatologists to medical and dermatology residents.​
Editors and Affiliations
-
Department of Dermatology, Yale School of Medicine, New Haven, USA
Oscar R. Colegio
About the editor
Oscar R. Colegio gained a PhD from Yale University (Department of Cell Biology) in 2003 and was awarded his MD by Yale University School of Medicine in the following year. After a residency and a fellowship in the Department of Dermatology at the university, Dr. Colegio became an Instructor of Dermatology at Yale in 2009, was appointed Assistant Professor in 2010, and was appointed Associate Professor of Dermatology, Pathology and Surgery in 2016. Dr. Colegio is a member of the Alpha Omega Alpha Honor Medical Society and a recipient of the Hugh L. Dwyer Resident Award for Clinical Excellence. In 2013 he was a finalist in the Damon Runyon Cancer Research Foundation Clinical Investigator Award. He has taught a variety of courses at Yale, including on Skin Physiology and Dermatologic Manifestations of Systemic Diseases. Since 2009 he has been a member of the Board of Directors and Chair of the Research Committee of the International Transplant Skin Cancer Collaborative. Dr. Colegio is a reviewer for a number of leading journals.
